Alimera Sciences (ALIM) Price-to-Earnings (P/E) Ratio
Price: $5.54
Market Cap: $301.29M
Avg Volume: 866.83K
Market Cap: $301.29M
Avg Volume: 866.83K
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Alimera Sciences's P/E ratios across different time periods:
- TTM: -20.50
- Annual: -5.49
- Quarterly: -22.67
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 2.39
- Price-to-Sales (P/S) Ratio: 1.37
Annual Ratios
Alimera Sciences Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-20.50
P/B Ratio (Annual)
2.39
P/S Ratio (Annual)
1.37
Alimera Sciences Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2023 | -5.49 | 2.39 | 1.37 |
| 2022 | -1.05 | -0.91 | 0.35 |
| 2021 | -7.74 | -12.99 | 0.57 |
| 2020 | -4.05 | -2.71 | 0.42 |
| 2019 | -3.46 | -8.13 | 0.67 |
| 2018 | -3.07 | 18.47 | 1.07 |
| 2017 | -4.05 | 5.97 | 2.48 |
| 2016 | -1.72 | 2.23 | 1.66 |
| 2015 | -3.51 | 4.09 | 4.79 |
| 2014 | -6.23 | 4.52 | 26.57 |
| 2013 | -3.21 | -30.14 | 79.29 |
| 2012 | -2.50 | 1.26 | 0.00 |
| 2011 | -1.74 | 1.57 | 0.00 |
| 2010 | -16.60 | 5.09 | 0.00 |
| 2009 | -0.38 | -3.10 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for ALIM.